| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39ae96c0ecc22ff90ff986371a3cea0f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6459 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 |
| filingDate |
1990-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_905c94de909a2541e77fa0c654d300fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af334eb97d17a7c0e6364b2b049b7c10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdc464a6f710ccfa9e80c41f1529430f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d81681cb7ac3a8f733131eef4b7d7a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6397df259f7194ed87c789b4f903b516 |
| publicationDate |
1990-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0379890-A1 |
| titleOfInvention |
New tissue plasminogen activator |
| abstract |
New tissue plasminogen activator which has a strong activity for converting plasminogen into plasmin and is useful as a thrombolytic agent comprising a nN-terminal peptide of plasminogen linked to t-PA having a special amino acid sequence; na DNA encoding amino acid sequence of the t-PA as mentioned; nan expression vector comprising the said DNA and a pharmaceutical composition comprising the said t-PA; nthe said t-PA is produced by culturing a host cell transformed with an expression vector comprising DNA encoding amino acid sequence of the said t-PA in a nutrient medium, and recovering the resultant t-PA from the cultured broth. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013039902-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9204450-A1 |
| priorityDate |
1989-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |